Literature DB >> 12732211

Potentiation of invasive activity of hepatoma cells by reactive oxygen species is mediated by autocrine/paracrine loop of hepatocyte growth factor.

Yutaka Miura1, Yasuhiro Kozuki, Kazumi Yagasaki.   

Abstract

We have already reported that reactive oxygen species (ROS) promote rat ascites hepatoma cell invasion beneath mesentery-derived mesothelial cell monolayer. To investigate the mechanism for this, we examined the involvement of motility factors, particularly hepatocyte growth factor (HGF). Rat ascites hepatoma cell line of AH109A expressed HGF and c-Met mRNAs. Treatment with ROS augmented amounts of HGF mRNA in AH109A and HGF concentration in the medium. ROS also induced HGF gene expression in mesothelial cells. Exogenously added HGF enhanced invasive activity of AH109A cells, but exerted no effect on proliferation. AH109A cells pretreated with ROS showed an increased invasive activity, which was cancelled by simultaneous pretreatment with anti-HGF antibody. These results suggest that the invasive activity of AH109A is mediated by the autocrine and paracrine pathways of HGF, and ROS potentiate invasive activity by inducing gene expression of HGF in AH109A and mesothelial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732211     DOI: 10.1016/s0006-291x(03)00725-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Resveratrol inhibits hepatoma cell invasion by suppressing gene expression of hepatocyte growth factor via its reactive oxygen species-scavenging property.

Authors:  Daiki Miura; Yutaka Miura; Kazumi Yagasaki
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

2.  HGF upregulates CXCR4 expression in gliomas via NF-kappaB: implications for glioma cell migration.

Authors:  Mine Esencay; Elizabeth W Newcomb; David Zagzag
Journal:  J Neurooncol       Date:  2010-02-16       Impact factor: 4.130

3.  Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor.

Authors:  Kyung Hee Lee; Jae Ryong Kim
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

4.  Inhibitory effect of gingerol on the proliferation and invasion of hepatoma cells in culture.

Authors:  Satoru Yagihashi; Yutaka Miura; Kazumi Yagasaki
Journal:  Cytotechnology       Date:  2008-01-23       Impact factor: 2.058

5.  Restoration by Prostaglandins E(2) and F (2) (alpha) of Resveratrol-Induced Suppression of Hepatoma Cell Invasion in Culture.

Authors:  Daiki Miura; Yutaka Miura; Kazumi Yagasaki
Journal:  Cytotechnology       Date:  2003-11       Impact factor: 2.058

6.  Inhibitory effect of ascorbic Acid on the proliferation and invasion of hepatoma cells in culture.

Authors:  Nobuhiro Hirakawa; Yutaka Miura; Kazumi Yagasaki
Journal:  Cytotechnology       Date:  2005-01       Impact factor: 2.058

7.  Blockade of endogenous reactive oxygen species by N-acetyl-L-cysteine suppresses the invasive activity of rat hepatoma cells by modulating the expression of hepatocyte growth factor gene.

Authors:  Yutaka Miura; Saho Tsukamoto; Kazumi Yagasaki
Journal:  Cytotechnology       Date:  2003-11       Impact factor: 2.058

8.  Anti-invasive activity of α-tocopherol against hepatoma cells in culture via protein kinase C inhibition.

Authors:  Shunsuke Yoshida; Nobuhiro Hirakawa; Katsuki Ito; Yutaka Miura; Kazumi Yagasaki
Journal:  J Clin Biochem Nutr       Date:  2011-04-13       Impact factor: 3.114

9.  Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells.

Authors:  Kyung Hee Lee; Sang Woon Kim; Jae-Ryong Kim
Journal:  J Exp Clin Cancer Res       Date:  2009-06-04

Review 10.  HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence.

Authors:  Jianjiang Fu; Xiaorui Su; Zhihua Li; Ling Deng; Xiawei Liu; Xuancheng Feng; Juan Peng
Journal:  Oncogene       Date:  2021-06-18       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.